Free tool
FAERS Monitor: Exelon
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022083 or its brand name (Exelon, Rivastigmine). Reports on generic versions are filed under their own applications.
Reports
18,807
Serious
16,024
85% of reports
Hospitalization
6,861
Death reported
4,787
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- death2,337
- fall1,791
- hallucination1,475
- confusional state1,331
- drug ineffective957
- vomiting909
- nausea858
- dizziness811
- gait disturbance751
- pneumonia728
- somnolence692
- fatigue681
- malaise673
- diarrhoea659
- condition aggravated653
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 323 |
| 2005 | 236 |
| 2006 | 201 |
| 2007 | 226 |
| 2008 | 611 |
| 2009 | 904 |
| 2010 | 943 |
| 2011 | 1,364 |
| 2012 | 1,451 |
| 2013 | 411 |
| 2014 | 611 |
| 2015 | 673 |
| 2016 | 941 |
| 2017 | 944 |
| 2018 | 984 |
| 2019 | 841 |
| 2020 | 1,048 |
| 2021 | 906 |
| 2022 | 936 |
| 2023 | 952 |
| 2024 | 1,009 |
| 2025 | 1,310 |
| 2026 | 977 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,035,352 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| hallucinationSignal | 1,475 | 22.3 | 21.2 | 29,513 |
| confusional stateSignal | 1,331 | 9.3 | 8.8 | 9,819 |
| fallSignal | 1,791 | 6.0 | 5.8 | 7,616 |
| gait disturbanceSignal | 751 | 4.4 | 4.1 | 1,981 |
| somnolenceSignal | 692 | 3.9 | 3.6 | 1,468 |
| deathSignal | 2,337 | 3.0 | 2.9 | 3,323 |
| pneumoniaSignal | 728 | 2.5 | 2.3 | 674 |
| condition aggravatedSignal | 653 | 2.4 | 2.2 | 541 |
| vomitingSignal | 909 | 2.2 | 2.0 | 580 |
| dizziness | 811 | 1.8 | 1.7 | 305 |
| malaise | 673 | 1.7 | 1.6 | 205 |
| nausea | 858 | 1.2 | 1.1 | 33 |
| diarrhoea | 659 | 1.1 | 1.1 | 12 |
| fatigue | 681 | 1.0 | 0.9 | 0 |
| drug ineffective | 957 | 0.8 | 0.8 | 44 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.